you need to read the preso to appreciate the significance of today's ann. To start with, the result was outstanding and it further increases the likelihood of success for other 3 phase 2 trials as they are more or less similar. Importantly, Neuren OWN the full commercial rights of all these indications and the potential size of the patient pool is 5 times bigger than Retts. FURTHER - there are hundreds of other autism related syndromes this drug can target. It's no longer a one trick pony but a full pipeline of indications!
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-8405
-
-
- There are more pages in this discussion • 2,711 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$16.15 |
Change
0.000(0.00%) |
Mkt cap ! $2.064B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1195 | $17.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.35 | 494 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 922 | 17.020 |
9 | 2973 | 17.010 |
2 | 183 | 16.950 |
1 | 212 | 16.850 |
3 | 1313 | 16.690 |
Price($) | Vol. | No. |
---|---|---|
15.350 | 494 | 1 |
15.720 | 3562 | 10 |
16.000 | 2504 | 3 |
16.010 | 915 | 3 |
16.100 | 392 | 1 |
Last trade - 10.06am 12/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |